Mary E Thompson1, Pete Driezen2,3, Christian Boudreau1, Nicolas Bécuwe4, Thomas K Agar2, Anne C K Quah2, Witold Zatoński5,6, Krzysztof Przewoźniak5,7, Ute Mons8, Tibor Demjén9, Yannis Tountas10, Antigona Trofor11,12, Esteve Fernández13,14,15,16, Ann McNeill17,18, Marc Willemsen9, Constantine Vardavas19,20, Geoffrey T Fong2,3,21. 1. Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. 2. Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada. 3. School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada. 4. Kantar Public (TNS), Brussels, Belgium. 5. Health Promotion Foundation, Warsaw, Poland. 6. European Observatory of Health Inequalities, President Stanisław Wojciechowski State University of Applied Sciences, Kalisz, Poland. 7. Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. 8. Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany. 9. Smoking or Health Hungarian Foundation (SHHF), Budapest, Hungary. 10. Center for Health Services Research, School of Medicine, National and Kapodistrian University of Athens (UoA), Athens, Greece. 11. University of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania. 12. Aer Pur Romania, Bucharest, Romania. 13. Tobacco Control Unit, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. 14. Tobacco Control Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. 15. School of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. 16. Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades, Respiratorias, CIBERES), Madrid, Spain. 17. Addictions Department, King's College London, London, UK. 18. UK Centre for Tobacco and Alcohol Studies, King's College London, London, UK. 19. European Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium. 20. Laboratory of Toxicology, School of Medicine, University of Crete (UoC), Heraklion, Greece. 21. Ontario Institute for Cancer Research, Toronto, Canada.
Abstract
BACKGROUND: The EUREST-PLUS ITC Europe surveys aim to evaluate the impact of the European Union's Tobacco Products Directive (EU TPD) implementation within the context of the WHO FCTC. This article describes the methodology of the 2016 (Wave 1) and 2018 (Wave 2) International Tobacco Control 6 European (6E) Country Survey in Germany, Greece, Hungary, Poland, Romania and Spain; the England arm of the 2016 (Wave 1) and 2018 (Wave 2) ITC 4 Country Smoking and Vaping (4CV) Survey; and the 2016 (Wave 10) and 2017 (Wave 11) ITC Netherlands (NL) Survey. All three ITC surveys covering a total of eight countries are prospective cohort studies with nationally representative samples of smokers. METHODS: In the three surveys across the eight countries, the recruited respondents were cigarette smokers who smoked at least monthly, and were aged 18 and older. At each survey wave, eligible cohort members from the previous waves were retained, regardless of smoking status, and dropouts were replaced by a replenishment sample. RESULTS: Retention rates between the two waves of the ITC 6E Survey by country were 70.5% for Germany, 41.3% for Greece, 35.7% for Hungary, 45.6% for Poland, 54.4% for Romania and 71.3% for Spain. The retention rate for England between ITC 4CV1 and ITC 4CV2 was 39.1%; the retention rates for the ITC Netherlands Survey were 76.6% at Wave 10 (2016) and 80.9% at Wave 11 (2017). CONCLUSION: The ITC sampling design and data collection methods in these three ITC surveys allow analyses to examine prospectively the impact of policy environment changes on the use of cigarettes and other tobacco products in each country, to make comparisons across the eight countries.
BACKGROUND: The EUREST-PLUS ITC Europe surveys aim to evaluate the impact of the European Union's Tobacco Products Directive (EU TPD) implementation within the context of the WHO FCTC. This article describes the methodology of the 2016 (Wave 1) and 2018 (Wave 2) International Tobacco Control 6 European (6E) Country Survey in Germany, Greece, Hungary, Poland, Romania and Spain; the England arm of the 2016 (Wave 1) and 2018 (Wave 2) ITC 4 Country Smoking and Vaping (4CV) Survey; and the 2016 (Wave 10) and 2017 (Wave 11) ITC Netherlands (NL) Survey. All three ITC surveys covering a total of eight countries are prospective cohort studies with nationally representative samples of smokers. METHODS: In the three surveys across the eight countries, the recruited respondents were cigarette smokers who smoked at least monthly, and were aged 18 and older. At each survey wave, eligible cohort members from the previous waves were retained, regardless of smoking status, and dropouts were replaced by a replenishment sample. RESULTS: Retention rates between the two waves of the ITC 6E Survey by country were 70.5% for Germany, 41.3% for Greece, 35.7% for Hungary, 45.6% for Poland, 54.4% for Romania and 71.3% for Spain. The retention rate for England between ITC 4CV1 and ITC 4CV2 was 39.1%; the retention rates for the ITC Netherlands Survey were 76.6% at Wave 10 (2016) and 80.9% at Wave 11 (2017). CONCLUSION: The ITC sampling design and data collection methods in these three ITC surveys allow analyses to examine prospectively the impact of policy environment changes on the use of cigarettes and other tobacco products in each country, to make comparisons across the eight countries.
Authors: M E Thompson; G T Fong; D Hammond; C Boudreau; P Driezen; A Hyland; R Borland; K M Cummings; G B Hastings; M Siahpush; A M Mackintosh; F L Laux Journal: Tob Control Date: 2006-06 Impact factor: 7.552
Authors: G T Fong; K M Cummings; R Borland; G Hastings; A Hyland; G A Giovino; D Hammond; M E Thompson Journal: Tob Control Date: 2006-06 Impact factor: 7.552
Authors: Gera E Nagelhout; Marc C Willemsen; Mary E Thompson; Geoffrey T Fong; Bas van den Putte; Hein de Vries Journal: BMC Public Health Date: 2010-06-18 Impact factor: 3.295
Authors: Geoffrey T Fong; Mary E Thompson; Christian Boudreau; Nicolas Bécuwe; Pete Driezen; Thomas K Agar; Anne C K Quah; Witold A Zatoński; Krzysztof Przewoźniak; Ute Mons; Tibor Demjén; Yannis Tountas; Antigona C Trofor; Esteve Fernández; Ann McNeill; Marc Willemsen; Constantine I Vardavas Journal: Tob Induc Dis Date: 2018-12-12 Impact factor: 2.600
Authors: Constantine I Vardavas; Nicolas Bécuwe; Tibor Demjén; Esteve Fernández; Ann McNeill; Ute Mons; Yannis Tountas; Antigona C Trofor; Aristides Tsatsakis; Gernot Rohde; Marc Willemsen; Krzysztof Przewozniak; Witold A Zatonski; Geoffrey T Fong Journal: Tob Induc Dis Date: 2018-08-21 Impact factor: 2.600
Authors: Filippos T Filippidis; Pete Driezen; Christina N Kyriakos; Paraskevi Katsaounou; Ioanna Petroulia; Charis Girvalaki; Marcela Fu; Esteve Fernández; Ute Mons; Antigona C Trofor; Tibor Demjén; Krzysztof Przewoźniak; Witold A Zatoński; Geoffrey T Fong; Yannis Tountas; Constantine I Vardavas Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Katerina Nikitara; Charis Girvalaki; Christina N Kyriakos; Pete Driezen; Filippos T Filippidis; Sarah Kahnert; Sara C Hitchman; Ute Mons; Esteve Fernández; Antigona C Trofor; Krzysztof Przewoźniak; Tibor Demjén; Paraskevi A Katsaounou; Witold Zatoński; Geoffrey T Fong; Constantine I Vardavas Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Janet Chung-Hall; Geoffrey T Fong; Gang Meng; Lorraine V Craig; Ann McNeill; Sara C Hitchman; Esteve Fernández; Ute Mons; Antigona C Trofor; Krzysztof Przewoźniak; Witold A Zatoński; Tibor Demjén; Paraskevi A Katsaounou; Christina N Kyriakos; Constantine I Vardavas Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Sophia Papadakis; Paraskevi Katsaounou; Christina N Kyriakos; James Balmford; Chara Tzavara; Charis Girvalaki; Pete Driezen; Filippos T Filippidis; Aleksandra Herbeć; Karin Hummel; Ann McNeill; Ute Mons; Esteve Fernández; Marcela Fu; Antigona C Trofor; Tibor Demjén; Witold A Zatoński; Marc Willemsen; Geoffrey T Fong; Constantine I Vardavas Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Constantine I Vardavas; Christina N Kyriakos; Pete Driezen; Charis Girvalaki; Katerina Nikitara; Filippos T Filippidis; Esteve Fernández; Ute Mons; Krzysztof Przewoźniak; Antigona C Trofor; Tibor Demjén; Paraskevi A Katsaounou; Witold Zatoński; Marc Willemsen; Geoffrey T Fong Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Sarah Aleyan; Pete Driezen; Ann McNeill; Máirtín McDermott; Sarah Kahnert; Christina N Kyriakos; Ute Mons; Esteve Fernández; Antigona C Trofor; Mateusz Zatoński; Tibor Demjén; Paraskevi A Katsaounou; Krzysztof Przewoźniak; James Balmford; Filippos T Filippidis; Geoffrey T Fong; Constantine I Vardavas; Sara C Hitchman Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Sarah Kahnert; Pete Driezen; James Balmford; Christina N Kyriakos; Sarah Aleyan; Sara C Hitchman; Sarah Nogueira; Tibor Demjén; Esteve Fernández; Paraskevi A Katsaounou; Antigona C Trofor; Krzysztof Przewoźniak; Witold A Zatoński; Geoffrey T Fong; Constantine I Vardavas; Ute Mons Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367
Authors: Sarah O Nogueira; Esteve Fernández; Pete Driezen; Marcela Fu; Olena Tigova; Yolanda Castellano; Ute Mons; Aleksandra Herbeć; Christina N Kyriakos; Tibor Demjén; Antigona C Trofor; Krzysztof Przewoźniak; Paraskevi A Katsaounou; Constantine I Vardavas; Geoffrey T Fong Journal: Nicotine Tob Res Date: 2022-01-01 Impact factor: 5.825
Authors: Shannon Gravely; Pete Driezen; Christina N Kyriakos; Mary E Thompson; James Balmford; Tibor Demjén; Esteve Fernández; Ute Mons; Yannis Tountas; Kinga Janik-Koncewicz; Witold Zatoński; Antigona C Trofor; Constantine I Vardavas; Geoffrey T Fong Journal: Eur J Public Health Date: 2020-07-01 Impact factor: 3.367